Fatigue in Inflammatory Bowel Disease (IBD): Diagnostic Workup and Management

Auteurs-es

  • Yaa Danso
  • Ailsa L. Hart
  • James Alexander
  • Calum D. Moulton

Résumé

Fatigue affects up to 72% of patients with inflammatory bowel disease (IBD), including up to 1 in 2 patients whose disease is in remission.1 

Beyond IBD treatments, few therapies for fatigue have been studied. The lack of clear success in clinical trials investigating fatigue treatments in IBD has left many clinicians without the therapeutic arsenal to manage this symptom.

This paper aims to provide a practical roadmap for busy clinicians to understand and incorporate IBD-related fatigue discussions within their consultations.

Biographies de l'auteur-e

Yaa Danso

Dr. Yaa Danso serves as a gastroenterology Registrar and IBD Clinical Research Fellow. Her research explores the impact and associations of fatigue in IBD patients, with a particular focus on investigating novel psychological and psychotropic treatment strategies. Beyond her research, Dr. Danso shares a strong commitment to addressing healthcare disparities and improving outcomes for underrepresented populations within gastroenterology.

Ailsa L. Hart

Professor Ailsa Hart is Director of Inflammatory Bowel Disease (IBD) Research at St Mark's Hospital, Consultant Gastroenterologist, and Clinical Senior Lecturer at Imperial College London. Internationally recognised for her expertise in IBD, Crohn›s disease, and ulcerative colitis, she leads one of the UK›s largest IBD services, caring for approximately 14,000 patients. A distinguished clinician, researcher, and educator, she has published over 400 peer-reviewed papers and two books. Professor Hart has held senior leadership roles within leading national and international gastroenterology organisations and has delivered invited lectures worldwide. She was recently recognised by Tatler as one of the UK›s top gastroenterologists.

James Alexander

Dr. James Alexander is a Consultant Gastroenterologist at St Mark’s Hospital and Honorary Clinical Senior Lecturer at Imperial College London. His clinical and research interests focus on inflammatory bowel disease (IBD), particularly the role of the gut microbiome in disease outcomes and treatment response. He was awarded the British Society of Gastroenterology Young Gastroenterologist of the Year in Clinical and Translational Science in 2023.

Calum D. Moulton

Dr. Calum Moulton is a Consultant Liaison Psychiatrist specialising in gastro‑psychiatry and complex gut disorders. He trained at Cambridge University, South London and Maudsley NHS Foundation Trust, and completed a PhD in Psychological Medicine at King’s College London. He holds an NIHR Advanced Fellowship and leads research focused on fatigue, depression, and gut-brain disorders in inflammatory bowel disease (IBD).

Références

Danso Y, Hart AL, Alexander JL, Moulton CD. Fatigue in inflammatory bowel disease: a practical guide for gastroenterology clinicians. Frontline Gastroenterology. Published Online First: 05 August 2025. doi:10.1136/flgastro-2024-103035

Farrell D, McCarthy G, Savage E. Self-reported symptom burden in individuals with inflammatory bowel disease. J Crohns Colitis. 2016;10(3):315-322. doi:10.1093/ecco-jcc/jjv218

Hawthorne AB, Christiansen P, Arnott I, Cummings JRF, Dobson L, Kent A, et al. Determining the care quality perception gap between patients and service providers: comparative analysis of 2019 and 2023 UK IBD benchmarking data from more than 26,000 adult patients and 154 IBD services. J Crohns Colitis. 2026;20(3):jjag005. doi:10.1093/ecco-jcc/jjag005

Czuber-Dochan W, Norton C, Bassett P, Berliner S, Bredin F, Darvell M, et al. Development and psychometric testing of the IBD Fatigue (IBD-F) questionnaire. J Crohns Colitis. 2014;8(11):1398-1406.

Regueiro M, Su S, Vadhariya A, Zhou X, Durand F, Stassek L, et al. Psychometric evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT-Fatigue) in adults with moderately to severely active Crohn’s disease. Qual Life Res. 2025;34(2):509-521. doi:10.1007/s11136-024-03829-3

Cella D, de la Loge C, Fofana F, Guo S, Ellis A, Fleurinck C, et al. The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) scale in patients with axial spondyloarthritis: psychometric properties and clinically meaningful thresholds for interpretation. J Patient Rep Outcomes. 2024;8(1):92. doi:10.1186/s41687-024-00769-x

Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci. 2001;933:185–200. doi:10.1111/j.1749-6632.2001.tb05824.x

Vogelaar L, de Haar C, Aerts BR, Peppelenbosch MP, Timman R, Hanssen BE, et al. Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters. Clin Exp Gastroenterol. 2017;10:83–90. doi:10.2147/CEG.S123942

Thong MSY, Noorden CJF, Steindorf K, Arndt V. Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol. 2020;21(2):17. doi:10.1007/s11864-020-0707-5. Erratum in: Curr Treat Options Oncol. 2022;23(3):450-451. doi:10.1007/s11864-021-00916-2

Carabotti M, Scirocco A, Maselli MA, Severi C. The gut–brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203–209. Erratum in: Ann Gastroenterol. 2016;29(2):240.

Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43(4):678–683. doi:10.1016/j.jacc.2003.07.050

Norton C, Czuber-Dochan W, Bassett P, Berliner S, Bredin F, Darvell M, et al. Assessing fatigue in inflammatory bowel disease: comparison of three fatigue scales. Aliment Pharmacol Ther. 2015;42(2):203–211. doi:10.1111/apt.13255

van Langenberg DR, Della Gatta P, Warmington SA, Kidgell DJ, Gibson PR, Russell AP. Objectively measured muscle fatigue in Crohn’s disease: correlation with self-reported fatigue and associated factors for clinical application. J Crohns Colitis. 2014;8(2):137–146. doi:10.1016/j.crohns.2013.07.006

Foster JA, McVey Neufeld KA. Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosc. 2013;36(5):305–312. doi:10.1016/j.tins.2013.01.005

Czuber-Dochan W, Norton C, Bredin F, Darvell M, Nathan I, Terry H. Healthcare professionals’ perceptions of fatigue experienced by people with IBD. J Crohns Colitis. 2014;8(8):835–844. doi:10.1016/j.crohns.2014.01.004

Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH. The role of sleep hygiene in promoting public health: a review of empirical evidence. Sleep Med Rev. 2015;22:23–36. doi:10.1016/j.smrv.2014.10.001

De Pasquale C, El Kazzi M, Sutherland K, Shriane AE, Vincent GE, Cistulli PA, et al. Sleep hygiene – what do we mean? A bibliographic review. Sleep Med Rev. 2024;75:101930. doi:10.1016/j.smrv.2024.101930

White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011;377(9768):823–836. doi:10.1016/S0140-6736(11)60096-2

Moulton CD, Jordan C, Hayee B, Chalder T. All-or-nothing behavior and catastrophic thinking predict fatigue in inflammatory bowel disease: a prospective cohort study. Inflamm Bowel Dis. 2024;30(10):1903–1906. doi:10.1093/ibd/izad193

Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;402(10414):1773–1785. doi:10.1016/S0140-6736(23)01523-4

Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, Van Oudenhove L. Neuromodulators for functional gastrointestinal disorders (disorders of gut–brain interaction): a Rome Foundation working team report. Gastroenterology. 2018;154(4):1140–1171. doi:10.1053/j.gastro.2017.11.279

Kent JM. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet. 2000;355(9207):911–918. doi:10.1016/S0140-6736(99)11381-3

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, et al. Safety reporting and adverse- event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute- phase treatment of adults with depression: systematic review and meta- analysis. CNS Drugs 2010;24(1):35–53. doi:10.2165/11319480-000000000-00000

Taylor D, Barnes TRE, Young A. The maudsley prescribing guidelines in psychiatry. Wiley- Blackwell; 2021. doi:10.1002/9781119870203

Kunz D, Dauvilliers Y, Benes H, García-Borreguero D, Plazzi G, Seboek Kinter D, et al. Long-term safety and tolerability of daridorexant in patients with insomnia disorder. CNS Drugs. 2023;37(1):93–106. doi:10.1007/s40263-022-00980-8

Gao T, Wang Z, Dong Y, Cao J, Lin R, Wang X, et al. Role of melatonin in sleep deprivation-induced intestinal barrier dysfunction in mice. J Pineal Res. 2019;67(1):e12574. doi:10.1111/jpi.12574

Flynn Pharma Ltd. Circadin 2 mg prolonged-release tablets – summary of product characteristics (SmPC). 2025 [Accessed 28 Apr 2025]. Available from: https://www.medicines.org.uk/emc/product/2809/smpc.

Nutt D, Wilson S, Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 2008;10(3):329–336. doi:10.31887/DCNS.2008.10.3/dnutt

Modafinil (Provigil): increased risk of congenital malformations if used during pregnancy. GOV.UK. 2020 [Accessed 28 Apr 2025]. Available from: https://www.gov.uk/drug-safety-update/modafinil-provigil-increased-risk-of-congenital-malformations-if-used-during-pregnancy.

Hart AL, Lomer M, Verjee A, Kemp K, Faiz O, Daly A, et al. What are the top 10 research questions in the treatment of inflammatory bowel disease? A priority setting partnership with the James Lind Alliance. J Crohns Colitis. 2017;11(2):204–211. doi:10.1093/ecco-jcc/jjw144

Téléchargements

Publié

2026-10-14

Comment citer

1.
Fatigue in Inflammatory Bowel Disease (IBD): Diagnostic Workup and Management. Can IBD Today [Internet]. 14 oct. 2026 [cité 14 oct. 2026];4(Issue 2):5-12. Disponible à: https://canadianibdtoday.com/article/view/4-1-YaaDanso_et_al

Numéro

Volume 4, Issue 2, Summer 2026

Rubrique

Articles

Licence

© Canadian IBD Today 2026

Licence Creative Commons

Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.

Comment citer

1.
Fatigue in Inflammatory Bowel Disease (IBD): Diagnostic Workup and Management. Can IBD Today [Internet]. 14 oct. 2026 [cité 14 oct. 2026];4(Issue 2):5-12. Disponible à: https://canadianibdtoday.com/article/view/4-1-YaaDanso_et_al